BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Di Giorgio A, Tulone A, Nicastro E, Norsa L, Sonzogni A, D'Antiga L. Use of oral vancomycin in children with autoimmune liver disease: A single centre experience. World J Hepatol 2021; 13(12): 2113-2127 [PMID: 35070012 DOI: 10.4254/wjh.v13.i12.2113]
URL: https://www.wjgnet.com/1948-5182/full/v13/i12/2113.htm
Number Citing Articles
1
Alessandra Elvevi, Alice Laffusa, Camilla Gallo, Pietro Invernizzi, Sara Massironi. Any Role for Microbiota in Cholangiocarcinoma? A Comprehensive ReviewCells 2023; 12(3): 370 doi: 10.3390/cells12030370
2
Cristo Yared Pérez Martin, José Ramón Alberto Alonso, Jenifer González Chávez, María Pilar Díaz Ruiz, Marta Suárez González, Javier Merino Alonso. [Translated article] Oral vancomycin in a pediatric patient with primary sclerosing cholangitis and inflammatory bowel diseaseFarmacia Hospitalaria 2023; 47(6): T297 doi: 10.1016/j.farma.2023.09.005
3
Eva Vlčková, Katarína Mitrová. Sclerosing cholangitis in children with inflammatory bowel diseaseČesko-slovenská pediatrie 2023; 78(3): 182 doi: 10.55095/CSPediatrie2023/025
4
Kai Markus Schneider, Martin Kummen, Palak J. Trivedi, Johannes R. Hov. Role of microbiome in autoimmune liver diseasesHepatology 2024; 80(4): 965 doi: 10.1097/HEP.0000000000000506
5
Ugo Cucinotta, Valeria Dipasquale, Claire Mayer, Angela Alibrandi, Bénédicte Pigneur, Servane Avril, Chiara Bergamo, Rossella Morello, Frank Rummele, Claudio Romano, Florence Lacaille. Does the SCOPE (Sclerosing Cholangitis Outcomes in PEdiatrics) index effectively predict later liver transplantation in children with sclerosing cholangitis?Digestive and Liver Disease 2025;  doi: 10.1016/j.dld.2025.03.021
6
Cristo Yared Pérez Martin, José Ramón Alberto Alonso, Jenifer González Chávez, María Pilar Díaz Ruiz, Marta Suárez González, Javier Merino Alonso. Vancomicina oral en un paciente pediátrico con colangitis esclerosante primaria y enfermedad inflamatoria intestinalFarmacia Hospitalaria 2023; 47(6): 297 doi: 10.1016/j.farma.2023.06.015